Coeptis Therapeutics Holdings, Inc.
USD0.01
+0.00 (+0.00%)
CEO
David Mehalick
IPO Date
2020-12-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.03
Market Cap
$0.00B
| 2,582 |
| $0.94 |
| 31 Aug 2023 | Calise Chris | director | P-Purchase | Acquired | 9,000 | $0.94 |
| 30 Aug 2023 | Salkind Gene | director | P-Purchase | Acquired | 28,638 | $0.91 |
| 30 Aug 2023 | Salkind Gene | director | P-Purchase | Acquired | 4,006 | $1.01 |
| 26 May 2021 | GLAZER CAPITAL, LLC | 10 percent owner | S-Sale | Disposed | 50,000 | $9.85 |
| 26 May 2021 | GLAZER CAPITAL, LLC | 10 percent owner | S-Sale | Disposed | 6,118 | $9.85 |
| 14 Dec 2020 | Bull Horn Holdings Sponsor LLC | 10 percent owner | J-Other | Disposed | 281,250 | $0.00 |
| 14 Dec 2020 | Calise Chris | director, 10 percent owner, officer: Chief Financial Officer | J-Other | Disposed | 281,250 | $0.00 |